Transition Therapeutics Inc.
Transition Therapeutics Inc. (TTHI) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 4 transactions totaling $2.7M, demonstrating a bullish sentiment with $2.7M in net insider flow. The most recent transaction on Nov 22, 2011 involved a purchase of 1,925,926 shares valued at $2.6M.
TTHI Insider Activity Summary
Who Is Buying TTHI Stock?
No significant insider buying has been recorded for TTHI in the recent period.
Who Is Selling TTHI Stock?
No significant insider selling has been recorded for TTHI in the recent period.
Is Transition Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TTHI is bullish with an Insider Alignment Score of 100/100 and a net flow of $2.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TTHI Frequently Asked Questions
Understanding TTHI Insider Activity
Insider trading at Transition Therapeutics Inc. (TTHI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading TTHI stock, having executed 4 transactions in the past 90 days. The most active insider is Jack W. Schuler (Executive), who has made 1 transactions totaling $2.6M.
Related Tools
Track Transition Therapeutics Inc. Insider Activity
Get notified when executives and directors at TTHI file new Form 4 transactions